Nanomedicines and Nanoproducts - Igarashi, Eiki
260,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Gebundenes Buch

This comprehensive book addresses the scope of practical nanoparticle applications in academic research as well as industrial investigation, offering an interdisciplinary, big-picture view of the current and future state of nanotechnology. The text provides a detailed overview of the disposition of nanoproducts within the body, with a special focus on the respiratory and olfactory routes of nanoproduct administration, buccal exposure and the ingestion of nanoproducts, the integumentary system, the ocular route, the systemic route, and toxicology as it relates to the nanoscale world.

Andere Kunden interessierten sich auch für
Produktbeschreibung
This comprehensive book addresses the scope of practical nanoparticle applications in academic research as well as industrial investigation, offering an interdisciplinary, big-picture view of the current and future state of nanotechnology. The text provides a detailed overview of the disposition of nanoproducts within the body, with a special focus on the respiratory and olfactory routes of nanoproduct administration, buccal exposure and the ingestion of nanoproducts, the integumentary system, the ocular route, the systemic route, and toxicology as it relates to the nanoscale world.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Eiki Igarashi is CEO of Nanosion Co., Ltd., a nanobioventure company in Tokyo, Japan. He is also a guest investigator at the National Institute of Advanced Industrial Science and Technology, Tokyo, Japan, where he collects and reviews medical information regarding the practical application, toxicology, and pharmacokinetics of nanoproducts and nanomaterials, ranging from metallic nanoparticles and carbon nanotubes to nanomedicines, nanofoods, nanocosmeceuticals, and nanoconsumer products. He holds a doctoral degree from Hiroshima University, Japan, and has worked in various capacities with Marion Merrell Dow Co., Ltd. (the pharmaceutical company of the Dow Chemical Company), Hirakata, Japan; Kyoto University, Japan; and Hoechst Marion Roussel Co., Ltd., Tokyo, Japan.